Qualigen Therapeutics Inc...

NASDAQ: QLGN · Real-Time Price · USD
1.89
0.13 (7.14%)
At close: Aug 15, 2025, 3:59 PM
1.91
1.06%
After-hours: Aug 15, 2025, 06:37 PM EDT

Qualigen Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
1.17M 401.8K 7.03M 17.54M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a 5.69K n/a
Other Long-Term Assets
2K 866.48K 24.02K 18.33K
Receivables
2.01M n/a 538.59K 822.35K
Inventory
n/a n/a 1.59M 1.06M
Other Current Assets
31.2K n/a 4.16M 3.58K
Total Current Assets
4.68M 1.17M 10.82M 20.8M
Property-Plant & Equipment
n/a n/a 1.77M 1.85M
Goodwill & Intangibles
n/a n/a 6.47M 171.19K
Total Long-Term Assets
2K 866.48K 8.26M 2.04M
Total Assets
4.69M 2.03M 19.08M 22.84M
Account Payables
1.57M 2.22M 619.57K 886.22K
Deferred Revenue
n/a n/a 116.16K 135.06K
Short-Term Debt
n/a 1.3M 60.2K 134.09K
Other Current Liabilities
269.18K 63.45K 7.18M 2.35M
Total Current Liabilities
2.01M 4.14M 8.61M 4.64M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a 1.3M n/a
Total Long-Term Liabilities
n/a n/a 1.71M 1.64M
Total Liabilities
2.01M 4.14M 10.32M 6.27M
Total Debt
n/a 1.3M 2.71M 1.68M
Common Stock
65.31K 43.26K 42.11K 35.29K
Retained Earnings
-123.06M -116.8M -103.39M -84.74M
Comprehensive Income
n/a n/a 50.72K n/a
Shareholders Equity
2.68M -2.1M 7.24M 16.56M
Total Investments
n/a n/a 5.69K n/a